Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNCR

Range Cancer Therapeutics ETF (CNCR) Price, Holdings, & News

About Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$11.63
$11.82
50-Day Range
$27.45
$32.25
52-Week Range
$8.84
$16.27
Volume
1,757 shs
Average Volume
6,114 shs
Market Capitalization
$6.93 million
Assets Under Management
$7.36 million
Dividend Yield
3.27%
Net Expense Ratio
0.79%
Aggregate Rating
Moderate Buy

ETF Overview

The Loncar Cancer Immunotherapy ETF (CNCR) is an exchange-traded fund that is based on the Loncar Cancer Immunotherapy index. The fund tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs. CNCR was launched on Oct 13, 2015 and is managed by Loncar.

Remove Ads

Range Cancer Therapeutics ETF Expenses

TypeCNCRHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.57%0.56%0.53%0.53%
Other Expenses0.00%0.30%0.49%0.43%0.52%
Total Expense0.79%0.70%0.72%0.68%0.71%
Fee Waiver0.00%-0.45%-0.50%-0.30%-0.55%
Net Expense0.79%0.61%0.63%0.62%0.60%
Receive CNCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter.

CNCR ETF News Headlines

Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Range Oncology Therapeutics Index ETF (CNCR)
See More Headlines

CNCR ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Range Cancer Therapeutics ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and e.l.f. Beauty (ELF).

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Range Cancer Therapeutics ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CNCR
Inception Date
10/13/2015
Fund Manager
Denise M. Krisko
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Range Cancer Therapeutics Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
76

Fund Statistics

Assets Under Management
$7.36 million
Average Daily Volume
$1,749.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
6,800 shs

Miscellaneous

Beta
0.93
Creation Unit
50,000
Creation Fee
$150.00
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Top 10 CNCR Holdings


This page (NASDAQ:CNCR) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners